Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,515 | -1,279 | -7,777 | -5,869 | -4,044 |
| Depreciation Amortization | 50 | 25 | -171 | -122 | -176 |
| Accounts receivable | 4 | N/A | -4 | -3 | -3 |
| Accounts payable and accrued liabilities | 7 | -249 | 675 | -100 | 474 |
| Other Working Capital | -520 | -557 | 1,281 | 196 | 635 |
| Other Operating Activity | 7,651 | 361 | 196 | 813 | -1 |
| Operating Cash Flow | $-2,323 | $-1,699 | $-5,800 | $-5,084 | $-3,115 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 518 | 1,756 | N/A | 1,606 |
| Debt Issued | 518 | N/A | N/A | 1,606 | N/A |
| Debt Repayment | -230 | N/A | N/A | -471 | N/A |
| Common Stock Issued | 1,763 | 1,103 | 4,275 | 3,635 | N/A |
| Other Financing Activity | 0 | -58 | -1,756 | 0 | -269 |
| Financing Cash Flow | $2,051 | $1,563 | $4,275 | $4,770 | $1,336 |
| Beginning Cash Position | 274 | 274 | 1,799 | 1,799 | 1,799 |
| End Cash Position | 3 | 139 | 274 | 1,485 | 21 |
| Net Cash Flow | $-272 | $-136 | $-1,525 | $-315 | $-1,778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,323 | -1,699 | -5,800 | -5,084 | -3,115 |
| Free Cash Flow | -2,323 | -1,699 | -5,800 | -5,084 | -3,115 |